Sentences with phrase «broad range of cancers»

High red meat consumption has been linked to heart disease, diabetes and a broad range of cancers, including prostate, bowel and pancreatic.

Then last March, a metastudy from Fudan University in Shanghai found that one extra cup of coffee daily correlates with a 3 percent reduced risk of a broad range of cancers.

Currently, studies for comprehensive application of TiY to a broader range of cancer examples are underway, together with screenings of anti-TIC drug platforms.

«This is the first approach using a patient's own immune cells that can specifically target this class of cancer - specific glycoantigens, and this has the great advantage of applicability to a broad range of cancers,» says first author Avery Posey, an instructor at the Perelman School of Medicine of the University of Pennsylvania.

Since SFRP2 is expressed in many cancers — including breast, colon, pancreas, ovarian and kidney tumors — the technique could potentially be useful on a broad range of cancer types.

In further studies, they plan to explore the role of autophagy in immune reactions toward other tumor cell types, to determine whether such therapies might be effective in a broad range of cancers.

His studies may kindle new therapeutic strategies relevant to a broad range of cancers.

At the ONJ Centre we treat a broad range of cancer types.

The research covers a broad range of cancer types, including breast, prostate, leukemia, glioma, pancreatic, sarcoma, lung and melanoma.

Every cancer is different and at the ONJ Centre we treat a broad range of cancer types.

The researchers note that PRISM makes it easier to profile a broad range of cancers — not only rare cancers but also cancers from populations whose genetics are traditionally underrepresented in research studies.

The Johns Hopkins Kimmel Cancer Center and Allegheny Health Network, we are working together to support cancer care and research through clinical collaborations, medical education, and a broad range of cancer research initiatives.

PD - 1 / PD - L1 inhibitors have already shown efficacy in a broad range of cancers and have been approved by the FDA for the treatment of melanoma; kidney; lung; head and neck cancer; bladder cancer; some forms of colorectal cancer; Hodgkin lymphoma and Merkel cell carcinoma.

Vyriad's product pipeline encompasses multiple clinical - and preclinical - stage programs that target a broad range of cancer indications as well as programs that pair the company's oncolytic viruses with other cancer immunotherapy modalities, traditional cancer therapy, and newer targeted therapies.